Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | +5.05% | +40.00% | -14.58% |
12:10pm | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
05-01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.